J&J’s 1-dose shot cleared, giving U.S. third COVID-19 vaccine

The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85% protective against the most severe COVID-19 illness, in a massive study that spanned three continents.